Press release from CNW Group
Scotiabank Announces Subordinated Debentures Offering
Friday, October 12, 2012
/NOT FOR RELEASE OR DISSEMINATION IN THE UNITED STATES/
TORONTO, Oct. 12, 2012 /CNW/ - Scotiabank today announced that it intends to issue $1.75 billion of 3.036% Subordinated Debentures due 2024 (the "Debentures") pursuant to its June 8, 2012 base shelf prospectus.
The Debentures, to be sold through an agency syndicate led by Scotiabank Global Banking & Markets, are expected to be issued on October 18, 2012. Interest will be payable semi-annually from the date of issue until October 18, 2019 at 3.036% per annum. From October 18, 2019 to maturity on October 18, 2024, the Debentures will pay a quarterly coupon at a rate of the 90 day bankers' acceptance plus 1.14%, beginning January 18, 2020.
Scotiabank intends to file, in Canada, a pricing supplement to its June 8, 2012 base shelf prospectus.
The Debentures have not been and will not be registered under the United States Securities Act of 1933, as amended, or under any state securities laws and, subject to certain exceptions, may not be offered, sold, or delivered directly or indirectly, within the United States of America, its territories and possessions or to, or for the account or benefit of, U.S. persons. This release does not constitute an offer to sell or a solicitation to buy the Debentures in the United States.
Scotiabank is one of North America's premier financial institutions and Canada's most international bank. With more than 81,000 employees, Scotiabank and its affiliates serve some 19 million customers in more than 55 countries around the world. Scotiabank offers a broad range of products and services including personal, commercial, corporate and investment banking. With assets of $670 billion (as at July 31, 2012), Scotiabank trades on the Toronto (BNS) and New York Exchanges (BNS). For more information please visit www.scotiabank.com.
For further information:
Jake Lawrence, Managing Director, Group Treasury, Scotiabank,
(416) 866-5712, or email@example.com